September 30, 2014 / 9:30 PM / 3 years ago

BUZZ-Ebola drug developers: Up after U.S. confirms first case

1 Min Read

** Canadian drugmaker Tekmira Pharmaceutical's U.S.-listed shares up 19 pct at $25.25 in extended trading

** BioCryst's shares up 19 pct at $11.60; Sarepta Therapeutics up 4 pct at $22.00; Newlink Genetics Corp up 17 pct at $25.01

** All companies have potential Ebola treatments

** U.S. health officials said on Tuesday the first patient had been diagnosed with the deadly Ebola virus in the country

** The U.S. Centers for Disease Control and Prevention confirmed the diagnosis

** No additional details were immediately available

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below